Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan
Kengo Tokunaga 1Chihiro Suzuki 2Miyuki Hasegawa 2Ikuo Fujimori 21Department of General Medicine, Kyorin University School of Medicine, Tokyo, Japan; 2Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan Correspondence: Kengo TokunagaDepartment of General Medicine, Kyorin Unive...
Saved in:
Main Authors: | Tokunaga K (Author), Suzuki C (Author), Hasegawa M (Author), Fujimori I (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
by: Mitsushige Sugimoto, et al.
Published: (2019) -
Status of Helicobacter pylori Eradication in Japan
by: Gwang Ha Kim
Published: (2017) -
Eradication Therapy for Pediatric Helicobacter pylori Infection
by: Ji-Hyun Seo, et al.
Published: (2017) -
Helicobacter pylori Eradication Therapy-associated Diarrhea
by: Hoon Gil Jo, et al.
Published: (2021) -
Antibiotic Resistance and Helicobacter pylori Eradication Therapy
by: Younghee Choe
Published: (2023)